Study to investigate safety, tolerability and pharmacokinetics of a single ascending dose of AZD1704

Study identifier:D0980C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, First Time in Man, Single-Centre, Randomised, Double-Blind (within panels), Placebo-Controller Study to Investigate Safety, Tolerability and pharmacokinetics of AZD1704 after Administration of Oral Single Ascending Doses in Healthy Volunteers

Medical condition

Pain

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD1704

Sex

All

Actual Enrollment

80

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Mar 2008
Primary Completion Date: 01 Jun 2008
Study Completion Date: 01 Jun 2008

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Other

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria